Related Experiment Videos

Distinctive features of procoagulant response of monocytes from diabetic patients

B Jude1, A Watel, O Fontaine

  • 1Laboratoire d'Hématologie, Centre Hospitalier Régional, Lille, France.

Haemostasis
|January 1, 1989
PubMed

Insights

Diabetic patients

Area of Science:

  • Hematology
  • Endocrinology
  • Immunology

Background:

  • Monocytes play a crucial role in hemostasis and inflammation.
  • Diabetes mellitus is associated with an increased risk of thrombotic events.
  • The procoagulant activity (PCA) of monocytes in diabetes is not fully understood.

Purpose of the Study:

  • To investigate the procoagulant activity (PCA) of monocytes in diabetic patients compared to healthy controls.
  • To characterize the nature of PCA in diabetic monocytes.
  • To explore potential correlations between PCA and clinical features of diabetes.

Main Methods:

  • Disrupted monocytes were isolated from 32 diabetic patients and 30 control subjects.
  • Procoagulant activity was measured before and after incubation, with and without lipopolysaccharide stimulation.
  • Factor VII and tissue factor-like activities were assessed.

Main Results:

  • Diabetes monocytes showed weak baseline PCA, sometimes associated with factor VII activity.
  • Incubation significantly increased PCA in diabetic monocytes, irrespective of stimulation.
  • Control monocytes' PCA increased only after stimulation.
  • PCA characteristics in diabetic monocytes varied based on associated factor VII levels.

Conclusions:

  • Monocytes from diabetic patients exhibit enhanced procoagulant activity compared to controls.
  • This heightened PCA may result from in vivo stimulation or increased in vitro responsiveness.
  • The findings suggest a potential contribution of monocyte PCA to the thrombotic risk in diabetes.

Related Concept Videos